Bayer heads into next U.S. cancer trial, opening statements set for Thursday

Despite Bayer AG’s efforts to put an end to costly litigation inherited in its acquisition of Monsanto, opening statements in yet another trial are set for Thursday as a woman suffering from non-Hodgkin lymphoma claims Monsanto’s Roundup herbicide caused her cancer. A jury of seven men and five women have been seated in the case … Bayer heads into next U.S. cancer trial, opening statements set for Thursday



























